C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/70 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01) C07D 401/12 (2006.01) C07D 403/04 (2006.01) C07D 403/12 (2006.01) C07D 407/12 (2006.01) C07D 409/12 (2006.01) C07D 409/14 (2006.01)
Patent
CA 2656618
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Formula (I). Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
La présente invention concerne des composés de formule (I) et leurs tautomères, leurs énantiomères résolus, leurs diastéréomères, leurs solvates, leurs métabolites et leurs sels, ainsi que leurs promédicaments pharmaceutiquement acceptables. [Insérer formule (I)]. L'invention concerne également des procédés d'utilisation des composés de la présente invention en tant qu'inhibiteurs de la protéine kinase AKT et pour le traitement de maladies hyperprolifératives telles que le cancer.
Banka Anna L.
Bencsik Josef R.
Blake James F.
Chabot Christine
Kallan Nicholas C.
Array Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Genentech Inc.
LandOfFree
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopenta [d] pyrimidines as akt protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopenta [d] pyrimidines as akt protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1801682